Señales en vivo de GNTA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 may 2024 @ 16:00):

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy...

Stats
Volumen de hoy	1 684.00
Volumen promedio	5 968.00
Capitalización de mercado	60.12M
EPS	$0 ( 2024-04-24 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.71
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2008-10-06	Driscoll Martin J	Buy	4 999	Options to acquire Common Stock
2008-04-11	Sanders Walter Lloyd	Buy	65 000	Restricted Stock Unit
2007-01-03	Sanders Walter Lloyd	Sell	53	Common Stock, par value $.001
2007-01-03	Sanders Walter Lloyd	Sell	51	Common stock, par value $.001
2007-07-11	Driscoll Martin J	Buy	30 000	Options to acquire Common Stock

INSIDER POWER
0.00
Last 60 transactions
Buy: 9 070 639 \| Sell: 19 095 969

Genenta Science S.p.A. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Genenta Science S.p.A. Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-41 582.00 (0.00 %)
EPS:	$-0.630

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-41 582.00 (0.00 %)
EPS:	$-0.630

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-6 029.42 (0.00 %)
EPS:	$-0.200

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.370

Financial Reports:

No articles found.

Genenta Science S.p.A. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Genenta Science S.p.A.

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. The company was incorporated in 2014 and is headquartered in Milan, Italy.